M. Protopopov

发表

ASK1 pharmacophore model derived from diverse classes of inhibitors.

S. Yarmoluk, A. Golub, V. Bdzhola, 2014, Bioorganic & medicinal chemistry letters.

Hit identification of FGFR 1 inhibitors using receptor-based virtual screening

S. Yarmoluk, A. Balanda, V. Bdzhola, 2019 .

Identification of 4‐methoxythieno[2,3‐d]pyrimidines as FGFR1 Inhibitors

S. Yarmoluk, A. Balanda, V. Bdzhola, 2019, Biopolymers and Cell.

Identification of Mycobacterium tuberculosis leucyl-tRNA synthetase (LeuRS) inhibitors among the derivatives of 5-phenylamino-2H-[1,2,4]triazin-3-one

O. P. Kovalenko, S. Yarmoluk, A. Yaremchuk, 2016, Journal of enzyme inhibition and medicinal chemistry.

Identification and characterization of potential membrane-bound molecular drug targets of methicillin-resistant Staphylococcus aureus using in silico approaches

S. Yarmoluk, V. Bdzhola, G. Volynets, 2019, Biopolymers and Cell.

Identification of membrane proteins as potential drug targets in Escherichia coli ATCC 25922 using in silico approaches

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2020, Biopolymers and Cell.

Evaluation of in vitro activity and SAR study of the novel hetarylamino-3-aryl-1H-indazole derivatives as inhibitors of protein kinase CK2

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2021, Biopolymers and Cell.

Flavone inspired discovery of benzylidenebenzofuran-3(2H)-ones (aurones) as potent inhibitors of human protein kinase CK2.

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2020, Bioorganic chemistry.

Search of protein kinaSe ck 2 inhibitorS baSed on purine-2 , 6-dioneS derivativeS

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2017 .

Development of receptor-based protein kinase Cβ (PKCβ) pharmacophore model for the search of inhibitors with potential activity against acute respiratory distress syndrome (ARDS)

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2022, Biopolymers and Cell.

The synthesis of 5-hetarylamino-3-aryl-1H-indazoles as inhibitors of protein kinase CK2

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2020, Biopolymers and Cell.

Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitors

S. Yarmoluk, S. Desenko, N. Gorobets, 2018, Molecular Diversity.

Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors

S. Yarmoluk, V. Dosenko, V. Bdzhola, 2022, Structural Chemistry.

Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitors

S. Yarmoluk, S. Desenko, N. Gorobets, 2018, Molecular Diversity.

The use of the docking studies with the purpose of searching Potential Antihypertensive Drugs

I. Sych, M. Protopopov, I. Drapak, 2019, Research Journal of Pharmacy and Technology.

Identification of novel protein kinase CK2 inhibitors among indazole derivatives

S. Yarmoluk, V. Bdzhola, M. Protopopov, 2021, Biopolymers and Cell.

Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2

S. Yarmoluk, O. B. Smolii, V. Bdzhola, 2017 .

Creation of targeted compound libraries based on 3D shape recognition

Dmytro V. Dudenko, M. Protopopov, A. Kyrylchuk, 2022, Molecular Diversity.

Hit identification of CK2 inhibitors by virtual screening

S. Yarmoluk, V. Bdzhola, S. Starosyla, 2017 .